Victoza
Novo Nordisk obesity drug shows added benefits
March 9, 2015Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight
New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …
Novo Nordisk obesity drug gets FDA nod
December 24, 2014Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda
The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …
Novo Nordisk to open $130 million diabetes labs
November 3, 2014Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes
Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …
FDA panel backs liraglutide for obesity
September 12, 2014Manufacturing and Production, Sales and Marketing Arena Pharmaceuticals, Belviq, Novo Nordisk, Qsymia, Victoza, Vivus, diabetes, obesity
An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …
Lilly’s diabetes drug matches Victoza
February 26, 2014Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly
Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …
Underwhelming results for Victoza
March 20, 2013Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk has reported underwhelming results for a well-established diabetes treatment in a late-stage trial designed to test its weight …
Positive data for Sanofi’s diabetes drug
June 13, 2012Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes
Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …
Victoza superiority to Januvia made official by FDA
April 10, 2012Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes
Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …
GSK’s diabetes drug misses goal
April 4, 2012Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes
GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …
Diabetes – the battle for control
February 15, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes
This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …
GSK diabetes drug fails head-to-head against Victoza
November 16, 2011Sales and Marketing GLP-1, Victoza, albiglutide, diabetes
GlaxoSmithKline’s long-acting diabetes drug albiglutide has failed in a head-to-head trial against Novo Nordisk’s Victoza. Albiglutide is an injectable glucagon-like …
Novo Nordisk’s Victoza launched in China
October 10, 2011Sales and Marketing Byetta, China, Victoza, diabetes
Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …
Fresh scrutiny for new diabetes drugs
September 15, 2011Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes
Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …
Victoza data shows promise for early setting
September 13, 2011Research and Development, Sales and Marketing Novo Nordisk, Victoza
New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …
Novo’s diabetes drug Victoza approved in China
March 16, 2011Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes
Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
